Back to Directory
Regular Human Insulin
Performance & EnduranceShort-acting human insulin for mealtime coverage, slower than analogs.
Key Benefits
- ✓Mealtime glucose coverage
- ✓Lower cost than analogs
- ✓Well-established safety
- ✓Can be used IV in hospital
- ✓Globally available
Dosing Information
Dosage Range
Variable
Frequency
Before meals (30 min)
Typical Duration
Lifelong
Detailed Protocol
Administered subcutaneously 30 minutes before meals. Can also be given intravenously in hospital setting. Dose based on carbohydrate intake and glucose.
About Regular Human Insulin
Regular human insulin (Humulin R, Novolin R) is unmodified human insulin produced via recombinant DNA technology. Takes 30-60 minutes to work, peaks at 2-3 hours. Slower than rapid-acting analogs but less expensive.
Research Notes
Standard human insulin since recombinant technology. Less convenient than rapid analogs but much less expensive. Important global access. IV formulation for DKA.
Potential Side Effects
- •Hypoglycemia
- •Weight gain
- •Requires 30-min waiting
- •Must time with meals
Always consult with a healthcare professional before starting any peptide therapy.